## Abstract Novel forms of contractile regulation observed in skeletal muscle are evident in neuromuscular diseases like rippling muscle disease (RMD). Previous studies of an autoimmune form of RMD (ARMD) identified a very high molecular weight skeletal muscle protein antigen recognized by ARMD pat
Sporadic rippling muscle disease unmasked by simvastatin
✍ Scribed by Steven K. Baker; Mark A. Tarnopolsky
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 125 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We report a 53‐year‐old‐man who developed rippling muscle disease (RMD) 2 months after starting simvastatin therapy for hypercholesterolemia. He experienced stiffness, myalgias, and classic rippling, which was confirmed on clinical examination. Discontinuation of the statin improved his symptoms. Simvastatin therapy was resumed and resulted in a prompt and severe return of his symptoms. Approximately 1 year after symptom onset he developed mild seropositive oculobulbar myasthenia gravis, which spontaneously remitted after 5 months. We postulate that an immune‐mediated disruption of caveolar function was exacerbated by statin exposure. We are unaware of any previous cases of statin‐mediated unmasking of RMD. Muscle Nerve, 2006
📜 SIMILAR VOLUMES